Navigation Links
FDA Panel Considers 1st Drug for Chronic Fatigue Syndrome
Date:12/20/2012

By Steven Reinberg
HealthDay Reporter

THURSDAY, Dec. 20 (HealthDay News) -- A U.S. Food and Drug Administration advisory committee will meet Thursday to consider approval of the first drug to treat chronic fatigue syndrome.

The experts will discuss the risks and benefits associated with the intravenous drug rintatolimod (proposed brand name Ampligen). The drug's maker, Hemispherx Biopharma of Philadelphia, failed to win the FDA's OK in 2009 because of concerns about study methodology.

Experts said they would welcome a treatment for this disabling condition that affects as many as 4 million Americans, mostly women. There is no cure, but the drug appears to reduce symptoms for some patients.

"It does seem to help at least a subset of patients significantly. For others, there isn't a significant response," said K. Kimberly McCleary, president of the Chronic Fatigue and Immune Dysfunction Syndrome Association of America.

"This drug has been studied in chronic fatigue syndrome since the late 1980s, so it's been around for a while," McCleary added.

Dr. Nancy Klimas, professor of medicine at Nova Southeastern University College of Osteopathic Medicine in Fort Lauderdale, Fla., who is part of an ongoing trial of the drug, said some of her patients have benefitted from the drug. Now there needs to be a way to identify which patients will do well on the drug, she added.

Chronic fatigue syndrome is little understood, and Ampligen's approval would give patients some standing with their insurers, Klimas said.

"Even a single approved therapy, even if it were one I choose not to use, would be very helpful when I am arguing with insurance companies to legitimize the condition and that it is serious enough to require an intervention," Klimas said.

According to the drug company, Ampligen is a new type of drug called a nucleic acid compound, which uses specially made RNA to target a variety of disea
'/>"/>

Copyright©2012 ScoutNews,LLC.
All rights reserved

Page: 1 2 3

Related medicine news :

1. CDC Panel: All Pregnant Women Should Get Whooping Cough Shot
2. U.S. Panel Rejects Ovarian Cancer Screens for Low-Risk Women
3. Expert panel calls for new research approach to prevent youth violence
4. Expert Panel Suggests PSA Test May Benefit Some Men
5. Few Patients Should Get Metal-on-Metal Hip Implants, FDA Panel Says
6. Screen All Adults for Obesity: U.S. Panel
7. FDA Panel Backs At-Home HIV Test
8. FDA Panel to Consider At-Home HIV Test
9. FDA Panel Gives Blessing to New Weight-Loss Drug
10. U.S. Panel Rejects Ovarian Cancer Screening
11. New treatment may relieve chronic shortness of breath
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2014)... (PRWEB) November 27, 2014 In ... individuals allot to sleep has lessened, and due ... laptops, the quality of sleep has eroded. According ... asleep on the job (Reference: http://www.webmd.com/sleep-disorders/features/sleep-deprivation-workplace ). ... productivity index by an incalculable amount, leading not ...
(Date:11/27/2014)... HealthDay Reporter , WEDNESDAY, Nov. ... to acquire a second language, new research suggests. But anyone ... gain a brain boost, the small study finds. ... study co-author Ping Li, co-director of the Center for Brain, ... more interesting, Li said, that "the brain networks of the ...
(Date:11/27/2014)... The founders of VIM & VIGR, a ... functioning compression socks, are proud to announce the debut of ... Gradient Pressure (TM) knitting technology that is designed to increase ... commitment to adding flair and style to a product that ... the eye of a writer at The New York ...
(Date:11/27/2014)... VogueQueen.com is making every effort to offer ... world. As the premier online supplier of elegant special ... release a huge selection of sexy prom dresses today. ... also providing many beautiful styles in its product line. ... discounted prices. , “VogueQueen.com hopes to provide a truly ...
(Date:11/27/2014)... Dallas, Texas (PRWEB) November 27, 2014 ... research report on Global Insulin industry. For an ... including definition, classification, application, industry chain structure, industry ... report on global Insulin industry covers information ... manufacturing process, product cost structure and much more. ...
Breaking Medicine News(10 mins):Health News:Research Shows Surprising Number of US Workers Affected by Lack of Sleep 2Health News:Some People May Be Pre-Wired to Be Bilingual 2Health News:Some People May Be Pre-Wired to Be Bilingual 3Health News:VIM & VIGR Announces Launch of Men’s Line of Compression Socks 2Health News:A New Collection of Sexy Prom Dresses Has Been Released by the Reliable Online Supplier VogueQueen.com 2Health News:Insulin Industry Analysis (Supply, Consumption) for China, America, Korea, France & Japan Research Now at ReportsnReports 2Health News:Insulin Industry Analysis (Supply, Consumption) for China, America, Korea, France & Japan Research Now at ReportsnReports 3
... cancer gene can be turned on and off , MONDAY, ... becomes a bully while his peers are becoming thoughtful and ... their development that allows them to grow into cancerous tissue, ... researchers have identified a chemical process that turns off the ...
... of ... Fruit, ORLANDO, Fla., Jan. 7 ... drink healthier, adding Sun Shower(TM) 100%,Nectarine Juices into a diet may be the ... of Sun Shower(TM) Nectarine Juices are,tremendous," said Chris New, founder, chairman and CEO ...
... DAVID,S, Bermuda, Jan. 7 Warner Chilcott,Limited (Nasdaq: ... present at the 26th,Annual JPMorgan Healthcare Conference on ... Time. Presenting for Warner Chilcott will be Paul,Herendeen, ... Warner Chilcott,s presentation will be webcast live for ...
... in Spanish . , A group of scientists ... and Molecular Biology at Universitat Autnoma de Barcelona, has published ... large quantities only in lung cancers, particularly those caused by ... not yet developed and lesions are precancerous. Thus this molecule ...
... trend, but reasons aren,t clear , , MONDAY, Jan. 7 (HealthDay ... risk of prostate cancer compared to those who forego the ... looked at all men born in Denmark between 1935 and ... lower incidence of prostate cancer than fathers did. , The ...
... 7 CoolTouch Inc., a pioneering,manufacturer of medical lasers, ... an additional 510(K) clearance from the U.S. Food,and Drug ... laser is designed to ablate fat in areas such ... of conventional liposuction in larger areas,such as the abdomen ...
Cached Medicine News:Health News:Some Immature Brain Cells May Promote Tumors 2Health News:Start Your Day the Sun Shower(TM) Way 2Health News:UAB research could improve the prognosis and treatment of lung cancer 2Health News:Fatherhood Tied to Higher Prostate Cancer Risk 2Health News:Fatherhood Tied to Higher Prostate Cancer Risk 3Health News:CoolTouch Introduces CoolLipo(TM) Laser System, Recently FDA Cleared for Laser-Assisted Lipolysis 2
(Date:11/26/2014)...   Regulus Therapeutics Inc . (NASDAQ: ... development of innovative medicines targeting microRNAs, today announced that ... of Regulus, will present a company overview at the ... the New York Palace Hotel on Wednesday, December 3, ... webcast at the time of the presentation and can ...
(Date:11/26/2014)... 26, 2014  BioScrip ® , Inc. (NASDAQ: BIOS ... Chief Executive Officer, will present at the Bank of America Merrill ... , , Date: , , , Wednesday, December 3, 2014 , ... , , , , Location: , , , Boca Raton ... BioScrip, Inc. BioScrip, Inc. is a leading ...
(Date:11/26/2014)... The medical magnetic resonance imaging (MRI) ... with world market revenues for 2013 at $5.1 ... types of medical imaging have led to improvements ... conditions in children and adults, each imaging procedure ... Medical Imaging Markets , analyzes the current and ...
Breaking Medicine Technology:Regulus to Present at the 26th Annual Piper Jaffray Healthcare Conference and Genetic Rx Conference 2Regulus to Present at the 26th Annual Piper Jaffray Healthcare Conference and Genetic Rx Conference 3Kalorama: Steady Growth in the Medical MRI Market 2Kalorama: Steady Growth in the Medical MRI Market 3
... , , ... that it will provide H1N1 flu vaccinations at select ... beginning Tuesday, December 29. , (Logo: http://www.newscom.com/cgi-bin/prnh/20090129/NE64371LOGO ... everyone to get an H1N1 flu vaccine. Massachusetts, ...
... , , , SEATTLE, Dec. 28 Cell Therapeutics, Inc. (CTI) ... CTI,s Board of Directors (the "Board of Directors") approved and adopted ... stock purchase right will be distributed for each common share held ... the rights are not exercisable, and are attached to and trade ...
Cached Medicine Technology:CVS/pharmacy to Provide H1N1 Vaccinations in Massachusetts, Virginia and Orange County, California 2Cell Therapeutics, Inc. Adopts Shareholder Rights Plan 2Cell Therapeutics, Inc. Adopts Shareholder Rights Plan 3Cell Therapeutics, Inc. Adopts Shareholder Rights Plan 4
... of controlled compression and cold, the Shoulder ... anatomically designed cuff provides complete shoulder coverage ... ordered with an extra long strap (12AXL) ... can be ordered as a single cuff, ...
... FUNCTIONAL ARM BRACE (FAB) was designed ... to make it useful as a ... ,Far more than an "Elbow ROM ... over forearm rotation (pronation and supination)., ...
... splint features a completely padded posterior ... designed to provide passive flexion to ... fasciitis or Achilles tendonitis. Its ... order left or right. A ...
Designed for forefoot relief and healing. This shoe has a unique wedge outsole and a soft nylon upper. We also added the hi-top upper to keep the foot held back and reduce slippage. Available in five...
Medicine Products: